High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel Disease
Antonio Di Narzo(Cardiovascular Institute of the South), Ke Hao(Boston University), Judy H. Cho(Cedars-Sinai Medical Center), Carrie Brodmerkel(Janssen (United States)), Andrew Kasarskis(Icahn School of Medicine at Mount Sinai), Radu Dobrin(Janssen (United States)), Joel T. Dudley(Hamilton Thorne (United States)), Lauren Peters(Sema4 (United States)), Katherine Li(Janssen (United States)), Brian Kidd, Carmen Argmann(Icahn School of Medicine at Mount Sinai), Eric E. Schadt(Program for Appropriate Technology in Health), Shannon Telesco(Janssen (United States))
Cited by 31
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Inflammatory Bowel Disease
|New England Journal of Medicine|2009|2.7k